Safety and Efficacy Study of CC312 for Moderate to Severe SLE

Abroad (travel likely)RecruitingPHASE1

Conditions

SLE - Systemic Lupus Erythematosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

West China Hospital, Sichuan University, Chengdu, Sichuan, China
Contact: Study coordinator (Qibing Xie) · xieqibing1971@163.com · +86-18980601299

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE2

Beverly Hills, United States · La Palma, United States

A Study of E6742 in Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE2

Bengbu, China · Beijing, China

A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Treatment of Lupus Nephritis With Allogeneic Mesenchymal Stem Cells

Lupus Nephritis · Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE2

Valladolid, Spain